Pancreatic Stone Articles & Analysis
3 news found
The score has obtained the authorization to sell in Europe (CE mark) and relies on PSP (pancreatic stone protein), a novel biomarker Abionic has already clinically validated and marketed. ...
Abionic SA, a developer of disruptive nanotechnology based rapid diagnostic solutions, announced today the successful completion of its multi-center observational study using Abionic’s novel point-of-care Pancreatic Stone Protein (PSP) sepsis test on the abioSCOPE® platform. ...
Delivering on this strategy, Abionic is about to launch a multinational sepsis impact study of it’s Pancreatic Stone Protein (PSP) test for sepsis risk assessment and management, the only device worldwide that provides results showing an indication of sepsis within 5 minutes. ...